Episode 2: Establishing the Evidence: Clinical Trials with TNF Inhibitors
Update: 2008-08-27
Description
Professor Smolen discusses the evidence supporting the ability of TNF-alpha agents to result in substantial and sustained improvement in symptoms of psoriatic arthritis. Agents including infliximab and etanercept result in not only clinical improvement but also slow the radiographic progression of joint disease and damage. Further, the combination therapy of a TNF-alpha agent and
methotrexate results in highly significant improvement in arthritic symptoms and signs.
methotrexate results in highly significant improvement in arthritic symptoms and signs.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
